Recent News

• 03.19.2026 - Collegium to Acquire AZSTARYS® from Corium Therapeutics, Strengthening Position in ADHD and Accelerating Growth Trajectory
• 03.05.2026 - Collegium to Present New Real-World Data at PainConnect 2026
• 03.03.2026 - Paris Hilton Shares Her Experience with JORNAY PM and Launches New 'Embrace Your Sparkle' Campaign with Collegium to Empower the ADHD Community
• 03.02.2026 - Collegium to Participate in Upcoming Investor Conferences
• 02.26.2026 - Collegium Reports Fourth Quarter and Full-Year 2025 Financial Results
• 02.23.2026 - Boston Legacy FC Announces Sensory Room Sponsorship with Collegium Pharmaceutical
• 02.12.2026 - Collegium to Report Fourth Quarter and Full-Year 2025 Financial Results on February 26, 2026

Recent Filings

• 03.20.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.19.2026 - EX-99.1 EX-99.1
• 03.19.2026 - 8-K Current report
• 03.18.2026 - 144 Report of proposed sale of securities
• 03.11.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.09.2026 - 144 Report of proposed sale of securities
• 03.05.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.03.2026 - 144 Report of proposed sale of securities
• 02.26.2026 - 8-K Current report
• 02.26.2026 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]